Sundararajan Venkatesh
Nephrology
353 New Shackle Island Rd Ste 249C
Hendersonville, TN 37075
Hendersonville, TN 37075
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
The mitochondrial protease, LonP1, is a potential cardioprotective target for attenuating doxorubicin-induced cardiomyocyte death.
Journal: Journal of translational medicine
Published: February 19, 2026
Traumatic brain injury impairs cardiac function independent of chronic cerebral hypoperfusion.
Journal: American journal of physiology. Heart and circulatory physiology
Published: January 27, 2026
The Integrated Stress Response Protein, eIF2α, Modulates UPRmt Signaling and Cell Death in Doxorubicin Treated Human Cardiac Cells.
Journal: Cardiovascular toxicology
Published: November 17, 2025
Systemic Lonp1 Haploinsufficiency Mitigates Cardiac Mitochondrial Dysfunction Induced by Cardiomyocyte-Specific Lonp1 Haploinsufficiency via Potential Inter-Organ Crosstalk.
Journal: Biomolecules
Published: July 17, 2025
Correction to: Mitochondrial complex-1 as a therapeutic target for cardiac diseases.
Journal: Molecular and cellular biochemistry
Published: September 04, 2024
Mitochondrial complex-1 as a therapeutic target for cardiac diseases.
Journal: Molecular and cellular biochemistry
Published: June 18, 2024
Child Neurology: Progressive Cerebellar Atrophy and Retinal Dystrophy: Clues to an Ultrarare ACO2-Related Neurometabolic Diagnosis.
Journal: Neurology
Published: January 17, 2023
Effect of hyperglycemia on tbx5a and nppa gene expression and its correlation to structural and functional changes in developing zebrafish heart.
Journal: Cell biology international
Published: May 29, 2022
A commentary on "PI3K-α/mTOR/BRD4 inhibitor alone or in combination with other anti-virals blocks replication of SARS-CoV-2 and its variants of concern including Delta and Omicron".
Journal: Clinical and translational discovery
Published: May 17, 2022
Inhibition of mitochondrial LonP1 protease by allosteric blockade of ATP binding and hydrolysis via CDDO and its derivatives.
Journal: The Journal of biological chemistry
Published: August 31, 2021
Understanding diabetes-induced cardiomyopathy from the perspective of renin angiotensin aldosterone system.
Journal: Pflugers Archiv : European journal of physiology
Published: May 19, 2021
Nampt Potentiates Antioxidant Defense in Diabetic Cardiomyopathy.
Journal: Circulation research
Published: April 30, 2021
Last Updated: 09/26/2026